Safety of NGOIS Compared to BSS Plus in Pediatric Patients

NCT00346528 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Cataract

Interventions

DRUG: Next Generation Ophthalmic Irrigating Solution (NGOIS)
DRUG: BSS Plus

Sponsor

Alcon Research